Viewing nowCombinationTelmisartan-Losartan Calcium Tablet 80/20 mg
Telmisartan 80mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Chong Kun Dang Pharmaceutical Corp.

MFDS item code 202101795 · Approved 2021.02.23
Treatment of hypertension and dyslipidemia; inhibition of atherosclerosis progression; prevention of cardiovascular disease
This medication is used for patients that require simultaneous administration of two ingredients, Telmisartan and Lovastatin. Telmisartan is effective in treating hypertension, particularly in patients over 55 years of age who are at high risk for cardiovascular disease, lowering the risk of myocardial infarction, stroke, and death. Lovastatin regulates cholesterol levels in patients with hypercholesterolemia and dyslipidemia, slowing the progression of atherosclerosis and reducing the risk of cardiovascular disease and stroke. These two medications are used when control through diet or exercise is inadequate. Therefore, this medication helps manage both hypertension and hyperlipidemia concurrently and reduces cardiovascular disease-related risks.
This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of each component, telmisartan and rosuvastatin. ○ Telmisartan 1. Essential hypertension Adults: The recommended dose is 40 mg orally once daily as telmisartan; 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When this medicine is coadministered with a thiazide diuretic such as hydrochlorothiazide, it has an additional blood pressure-lowering effect. When the dose is increased, the maximum blood pressure-lowering effect is reached 4 ∼ 8 weeks after the start of treatment. 2. Reduction of cardiovascular risk Adults: The recommended dose of this medicine is 80 mg orally once daily. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. 3. Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily. ○ Rosuvastatin calcium 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout treatment. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer, according to LDL cholesterol levels, the treatment goal, and the patient's response; the dose may be increased to a maximum of 20 milligrams once daily. 2. Older adults: No dose adjustment is required. 3. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution is required when administering 20 mg of this medicine to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score above 9. Do not administer this medicine to patients with active liver disease. 5. Race: Since systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients. Patients taking telmisartan and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.
This medication may cause serious harm to the fetus and newborns if taken during pregnancy, and use should be immediately discontinued upon confirmation of pregnancy. Patients with allergy to this medication or its components, pregnant or potentially pregnant women, nursing mothers, and women of childbearing age not using adequate contraception should not take this medication. The use of this medication in patients with severe liver dysfunction, bile duct obstruction or cholestasis, unexplained significantly elevated liver enzymes, muscular disorders, hereditary angioedema, severe renal impairment, patients on certain immunosuppressants, and patients with diabetes or moderate to severe renal impairment is contraindicated or requires caution. Elderly individuals, patients with hyperkalemia, mild to moderate liver impairment, valvular heart disease or ischemic heart disease, gastrointestinal disease, renal vascular hypertension, and severe myasthenia gravis require careful use of this medication. This medication may cause musculature-related side effects such as myalgia, myopathy, and rhabdomyolysis, so if symptoms of muscle pain or weakness occur, it is essential to consult a physician immediately. This medication can cause liver function abnormalities, so regular liver function tests are necessary before and during use, and the medication should be stopped if liver enzyme levels rise significantly. If symptoms of low blood pressure occur, they should be reported immediately, as this medication may cause blood pressure to drop too low, particularly in patients with low blood volume or those taking diuretics. This medication may interact with other antihypertensives, diuretics, potassium supplements, certain antibiotics, and antifungals, so if patients are taking other medications, they should inform their doctor or pharmacist. Caution is required when driving or operating machinery, as drowsiness or dizziness may occur. The safety and efficacy of this medication in children have not been established, and thus it is not recommended for use in this population. In cases of overdose, hypotension, dizziness, acute renal failure, etc., immediate contact with a medical facility is essential, and appropriate treatment should be sought. This medication contains lactose, so individuals with lactose intolerance should not take it. While taking this medication, symptoms such as muscle pain, weakness, dizziness, dyspepsia, and liver dysfunction may occur, so it is important to consult a physician immediately if these symptoms appear.
Increased ALT, Increased AST, Elevated serum creatine phosphokinase (CPK), Dizziness, Itching, Dyspepsia, Oral paresthesia, Musculoskeletal stiffness, Acne, Nasopharyngitis, Increased serum potassium, Glucosuria, Dysuria, Rhinitis, Discomfort in the oropharynx, Pulmonary disease, Unspecified gastrointestinal disorder, Benign gastrointestinal neoplasm, Hemorrhoids, Skeletal pain, Osteoporosis, Sensory disturbance, Movement disorders, Atherosclerosis, Frequent urination, Tinnitus, Hearing loss, Halitosis, Fatty liver, Upper respiratory tract infection, Urinary tract infection, Sepsis, Anemia, Thrombocytopenia, Eosinophilia, Hypersensitivity, Anaphylactic reaction, Hyperkalemia, Hypoglycemia, Depression, Insomnia, Anxiety, Syncope, Visual disturbances, Dizziness, Bradycardia, Tachycardia, Hypotension, Orthostatic hypotension, Dyspnea, Abdominal pain, Diarrhea, Abdominal distension, Vomiting, Abdominal discomfort, Dry mouth, Liver function abnormalities, Liver disease, Increased sweating, Rash, Erythema, Angioedema, Drug rash, Toxic skin rash, Eczema, Urticaria, Myalgia, Low back pain, Muscle cramps, Arthralgia, Pain in limbs, Tendon pain, Acute renal failure, Chest pain, Weakness, Influenza-like illness, Increased serum creatinine, Increased serum uric acid, Elevated liver enzymes, Increased serum CK, Decreased hemoglobin, Headache, Facial spasms, Paresthesia, Paralysis, Cough, Hyperventilation, Pneumonia, Flushing, Erectile dysfunction, Loss of appetite, Arrhythmia, Weakness, Edema, Reduced libido, Facial edema, Alopecia, Conjunctivitis, Tinnitus, Petechia, Polyneuropathy, Amnesia, Peripheral neuropathy, Diarrhea, Thrombocytopenia, Jaundice, Hepatitis, Stevens-Johnson syndrome, Eosinophilia and systemic symptoms associated drug reaction syndrome, Lupus-like syndrome, Muscle rupture, Arthralgia, Immune-mediated necrotizing myopathy, Hematuria, Edema, Depression, Sleep disorders, Sexual dysfunction, Gynecomastia, Liver failure, Cognitive impairment, Myasthenia gravis, Ocular myasthenia, Myopathy, Myositis, Rhabdomyolysis, Nausea, Palpitations, Fatigue, Insufficient effect, Numbness, Chest discomfort, Loss of appetite, Abdominal distension, Widespread pain, Muscle cramps, Gout
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to prevent exposure to air or moisture, with a recommended storage temperature between 1 and 30 degrees Celsius. Proper storage helps to maintain the effectiveness of the medication for a longer period.
Light pink oval film-coated tablet
30 tablets/box [(10 tablets/PTP x 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 80mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Chong Kun Dang Pharmaceutical Corp.
CombinationTelmisartan 80mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Yuhan Corporation.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Yuhannanghang Co., Ltd.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Yuhan Corporation Co., Ltd.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 40mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.